Gonal-F 300 IU Pen
|Other Names:||Organon European Packaging|
|Active Ingredient:||Follitropin Alfa|
|Maker:||Organon European Packaging|
In fertility treatments, Gonal-F 300 IU pen (SubQ) is a drug that encourages the ovaries to create many follicles (fluid-filled sacs containing eggs). Follicle-stimulating hormone (FSH), which is typically generated by the pituitary gland in the brain, is present in it in recombinant form.
A healthcare professional will choose the dosage and timing of the follitropin alfa injections based on the patient’s age, weight, and reproductive history. Follitropin Alfa (Gonal F) therapy typically starts on the second or third day of the menstrual cycle and lasts for 8 to 14 days.
Those with specific medical concerns, such as ovarian cysts or tumors, thyroid or adrenal gland issues, or a history of blood clots, should take Gonal-f cautiously. It could also make having multiple pregnancies more likely (such as twins or triplets). Before starting therapy, patients should talk with their healthcare professional about the advantages and disadvantages of Gonal F 300.
A drug called Gonal F 300 IU pen is used in assisted reproductive technology (ART) to encourage the growth of many follicles (egg sacs) in the ovaries. Follicle-stimulating hormone (FSH), a hormone that controls the formation and development of follicles in the ovaries, is present in it in a synthetic form.
The pen is a multi-dose, pre-filled injectable tool that is administered subcutaneously (below the skin). It is simple to use and convenient for people receiving in vitro fertilization treatment since it gives a precise amount of follitropin alfa with each injection.
Human chorionic gonadotropin (hCG) and other drugs, such as follitropin alfa, are frequently used to induce ovulation and boost the likelihood of conception.